We recently published 13 Best ADR Stocks to Invest In. GSK plc (NYSE:GSK) is one of the best ADR stocks. GSK plc (NYSE:GSK) ...
AJ1-11095 is a first-in-class Type II JAK2 inhibitor currently in a Phase 1 study for the treatment of patients with ...
GSK gains FDA Orphan Drug Designation for risvutatug rezetecan, adding momentum to its fast-advancing solid-tumor pipeline.
StudyFinds on MSN
Study: Lack of Diversity in Drug Trials Can Harm Patients
Only 6% of trials for FDA-approved drugs match America's diversity. Analysis reveals how trial location and design choices ...
London: GSK plc has announced that its B7-H3-targeted antibody-drug conjugate GSK'227, now referred to by its International ...
The IRA requires health plans serving the Part D market to cover all negotiated drugs, and it has been predicted that CMS ...
Officially lowering the evidentiary bar creates a predictable risk: more companies may highlight their most favorable study while downplaying or withholding less supportive results -- data the public ...
The patchwork rollout of a gene therapy exposes weaknesses in the pricing and regulatory frameworks that determine who ...
Ajax Therapeutics receives US FDA’s Orphan Drug Designation for AJ1-11095 to treat patients with myelofibrosis: New York Friday, December 12, 2025, 12:00 Hrs [IST] Ajax Therapeu ...
Ophirex announced that varespladib, which is also being developed as an oral rescue treatment for snakebite envenomation in ...
US FDA grants Orphan Drug Designation to GSK’227, a B7-H3-targeted antibody-drug conjugate to treat small-cell lung cancer: London, UK Thursday, December 11, 2025, 09:00 Hrs [IS ...
Swedish Orphan Biovitrum Ab ($GB:0MTD) announced an update on their ongoing clinical study. Swedish Orphan Biovitrum Ab has recently completed a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback